To determine if patients need additional treatment called immunotherapy to prevent cancer from coming back after having the bladder surgically removed after being diagnosed with bladder cancer.
Thank you for your interest, but this study will start enrolling soon.
United States (Nationwide)
Matthew Milowsky
LCCC - Clinical Trials
Clinical or Medical
Interventional
Cancer (Bladder)
24-0094
Copyright © 2013-2022 The NC TraCS Institute, the integrated home of the NIH Clinical and Translational Science Awards (CTSA) Program at UNC-CH. This website is made possible by CTSA Grant UL1TR002489 and the National Center for Advancing Translational Sciences.
Questions?
